Onconetix, Inc.
For the period ended Jun 30, 2025. Filed Aug 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 14, 2025
ONCO$3.58-48.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
(Unaudited)
| June 30, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| ASSETS | ||
| Current assets | ||
| Cash | $283,515 | $646,500 |
| Accounts receivable, net | 12,156 | 25,717 |
| Inventories | 153,072 | 64,079 |
| Prepaid expenses and other current assets | 481,788 | 213,971 |
| Total current assets | 930,531 | 950,267 |
| Property and equipment, net | 43,809 | 62,896 |
| Operating right of use asset | 21,400 | 119,427 |
| Goodwill | 18,123,296 | 27,048,973 |
| Total assets | $19,119,036 | $28,181,563 |
| LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities | ||
| Accounts payable | $2,581,608 | $3,787,564 |
| Accrued expenses | 894,986 | 888,988 |
| Notes payable, net of debt discount of $71,078 and $4,966 at June 30, 2025 and December 31, 2024, respectively | 8,731,571 | 9,328,061 |
| Operating lease liability, current | 21,400 | 119,427 |
| Subscription agreement liability – Related Party | — | 4,123,000 |
| Contingent warrant liabilities | 53,113 | 43,089 |
| Due to Shareholders | 409,510 | — |
| Total current liabilities | 12,692,188 | 18,290,129 |
| Pension benefit obligation | 73,644 | 280,879 |
| Total liabilities | 12,765,832 | 18,571,008 |
| Commitments and Contingencies | ||
| Series C Redeemable Preferred Stock, $0.00001 par value, 10,000 shares authorized, 2,130 and 3,499 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively | 443,443 | 1,067,928 |
| Stockholders’ equity | ||
| Common stock, $0.00001 par value, 250,000,000 shares authorized at June 30, 2025 and December 31, 2024; 1,009,126 and 138,422 the shares issued at June 30, 2025 and December 31, 2024, respectively; 1,008,974 and 138,270 shares outstanding at June 30, 2025 and December 31, 2024, respectively | 10 | 1 |
| Additional paid-in capital | 135,021,431 | 127,825,743 |
| Treasury stock, at cost; 152 shares of common stock at June 30, 2025 and December 31, 2024 | (625,791) | (625,791) |
| Due from shareholders | — | (250,308) |
| Accumulated deficit | (128,100,543) | (115,683,621) |
| Accumulated other comprehensive loss | (385,346) | (2,723,397) |
| Total stockholders’ equity | 5,909,761 | 8,542,627 |
| Total liabilities, convertible preferred stock, and stockholders’ equity | $19,119,036 | $28,181,563 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.